MetLife, Inc. $MET Position Cut by NewEdge Advisors LLC

NewEdge Advisors LLC reduced its holdings in MetLife, Inc. (NYSE:MET) by 8.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 61,624 shares of the financial services provider’s stock after selling 5,327 shares during the quarter. NewEdge Advisors LLC’s holdings in MetLife were worth $4,358,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in MET. Strs Ohio lifted its stake in shares of MetLife by 16.6% in the 4th quarter. Strs Ohio now owns 326,091 shares of the financial services provider’s stock worth $25,742,000 after acquiring an additional 46,469 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH raised its holdings in MetLife by 2.1% during the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 714,193 shares of the financial services provider’s stock worth $56,712,000 after purchasing an additional 14,515 shares in the last quarter. PFA Pension Forsikringsaktieselskab bought a new stake in MetLife during the fourth quarter worth approximately $81,494,000. Evergreen Capital Management LLC boosted its stake in MetLife by 195.8% during the 4th quarter. Evergreen Capital Management LLC now owns 33,260 shares of the financial services provider’s stock valued at $2,626,000 after purchasing an additional 22,016 shares in the last quarter. Finally, Principal Financial Group Inc. increased its position in shares of MetLife by 2.2% during the 4th quarter. Principal Financial Group Inc. now owns 622,789 shares of the financial services provider’s stock valued at $49,163,000 after purchasing an additional 13,657 shares during the period. Institutional investors own 94.99% of the company’s stock.

MetLife Stock Performance

Shares of NYSE MET opened at $96.78 on Wednesday. The stock’s fifty day simple moving average is $90.68 and its 200 day simple moving average is $81.14. The stock has a market capitalization of $62.27 billion, a price-to-earnings ratio of 18.54, a PEG ratio of 0.75 and a beta of 0.78. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. MetLife, Inc. has a 52-week low of $67.33 and a 52-week high of $100.93.

MetLife (NYSE:MET) last announced its earnings results on Wednesday, August 5th. The financial services provider reported $2.43 EPS for the quarter, beating the consensus estimate of $2.30 by $0.13. MetLife had a return on equity of 23.39% and a net margin of 4.57%.The business had revenue of $13.52 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same period in the prior year, the business posted $2.02 earnings per share. MetLife’s revenue was up 10.5% compared to the same quarter last year. As a group, sell-side analysts forecast that MetLife, Inc. will post 9.75 earnings per share for the current fiscal year.

MetLife declared that its board has approved a share repurchase program on Wednesday, August 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to reacquire up to 4.8% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s board believes its stock is undervalued.

MetLife Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 4th will be issued a $0.5925 dividend. This represents a $2.37 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Tuesday, August 4th. MetLife’s dividend payout ratio (DPR) is presently 45.40%.

Analyst Ratings Changes

MET has been the subject of several research reports. JPMorgan Chase & Co. raised their target price on MetLife from $106.00 to $108.00 and gave the company an “overweight” rating in a research note on Tuesday. Piper Sandler boosted their price target on shares of MetLife from $86.00 to $90.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 24th. TD Cowen raised their price objective on shares of MetLife from $87.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, July 22nd. Atlantic Securities set a $103.00 price objective on shares of MetLife in a research note on Wednesday, July 15th. Finally, Morgan Stanley boosted their target price on shares of MetLife from $93.00 to $103.00 and gave the stock an “overweight” rating in a report on Monday, July 6th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $101.07.

MetLife News Roundup

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: JPMorgan raised its price target for MetLife from $106 to $108 and maintained an “overweight” rating. The new target implies approximately 11.6% upside from the referenced $96.78 level, signaling continued confidence in the insurer’s earnings and valuation. Benzinga report
• Positive Sentiment: Keefe, Bruyette & Woods also increased its price target from $105 to $108 and reaffirmed an “outperform” rating. The second target increase reinforces the constructive analyst view of MetLife’s prospects. Benzinga report Ticker Report article
• Neutral Sentiment: MetLife Pet Insurance announced a partnership with America’s VetDogs to help co-raise a future service dog for a veteran or first responder with disabilities. The initiative may enhance brand reputation and community engagement, but is unlikely to materially affect near-term financial results. MetLife Pet Insurance and America’s VetDogs partnership
• Neutral Sentiment: MetLife highlighted benefits and employee well-being in its 2025 Sustainability Report. The disclosure may support long-term stakeholder and corporate-responsibility goals, though it is not an immediate earnings catalyst. MetLife 2025 Sustainability Report

MetLife Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.